The Indian government has published a 10-year national bioeconomy roadmap sector, which includes a focus on alternative ...

The company says recent investments in manufacturing and overseas expansion should start paying off over the next few ...

Bumble bees with no prior training on the complete task spontaneously rolled a ball beneath an out-of-reach sugar reward and stood on it to feed, solving an object-manipulation problem that echoes the ...

Clearmind Medicine Inc. (Nasdaq: CMND), a clinical-stage biotechnology company pioneering nonhallucinogenic neuroplastogenderived treatments for Alcohol Use Disorder (AUD), addiction, and weight ...

Inhibrx is transitioning from a platform to a clinical-stage biotech, with ozekibart and INBRX-106 as key value drivers.

The Energy Regulatory Commission (ERC) has temporarily suspended the power delivery service (PDS) charges for qualified energy storage systems (ESS) to support grid reliability. The commission noted ...

Gain Therapeutics, Inc. (Nasdaq: GANX) ('Gain”, or the 'Company”), a clinical-stage biotechnology company leading the discovery and development of the next generation of allosteric small molecule ...

London hosted the fifth meeting of the Economic and Social Pillar of the Saudi-UK Strategic Partnership Council, co-chaired ...

Every so often, a wave of demand in one corner of medicine spills over and creates an entirely new market next ...

ResMed's (ASX:RMD) reputation as the most resilient pillar of the Big Four life sciences stocks has come into question since ...

Praxis Precision Medicines Inc. (NASDAQ:PRAX) is one of the 10 affordable biotech stocks to buy right now. On July 7, Praxis ...

Frances Arnold on directed enzyme evolution: random mutation plus smart screening, and why it changed enzyme engineering and ...